Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy

Phase 1

Completed

• Conditions: Stroke; Transient Ischemic Attack; Myocardial Infarction

• Registration Number: NCT01495845
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

The purpose of this study is to determine the feasibility of pharmacogenomics testing in a community pharmacy using clopidogrel as an example. The investigators hypothesize that this testing is feasible in this setting.

Detailed Description

To determine if the study is feasible, we will examine the change in patient perception of pharmacogenomics testing (before and after the study), the percentage of patients interested in this service, the response rate of providers to pharmacist recommendations, the pharmacist time requirement, and reimbursement rate for pharmacist services.

Study Timeline

• Study Start: 2011-12
• Study First Submitted: 2011-12-16
• Study First Submitted QC: 2011-12-19
• Study First Posted: 2011-12-20
• Status Verified: 2012-06
• Primary Completion: 2012-06
• Study Completion: 2012-06
• Last Update Submitted: 2012-06-07
• Last Update Posted: 2012-06-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Prescribed clopidogrel (Plavix) by their prescriber
• Aged 18 or older
• Currently on clopidogrel therapy for one of the following indicated uses: post-ACS, Recent PCI with stenting, History of TIA or stroke

Read More

Exclusion Criteria

• Are unable to complete study materials (surveys) with or without assistance, including non-English speaking patients
• Are taking clopidogrel for a reason other than stated in inclusion criteria
• Are pregnant or nursing
• Have an allergy to aspirin

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Feasibility of Pharmacogenomics testing in a Community pharmacy	3 months	Change in patient perception of testing, reimbursement for pharmacist time, provider acceptance, and amount of pharmacist time required will be measured as part of the provision of this service.

Trial Locations

Locations (1)

Kerr Drug; 🇺🇸 Chapel Hill, North Carolina, United States